Skip to content
Clinical Trials – home
SpainBack to Spain

Clinical trials in Algeciras

4 clinical trials in Algeciras, Spain. Every trial is listed in the EU Clinical Trials Register and updated daily.

SpainOur site in SpainEnsayosClinicos.es(opens in a new tab)
Algeciras at a glance
4
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

4 trials in Algeciras

Open in trial search

Mite allergy

Recruiting

A study testing dust mite allergy extracts from Dermatophagoides pteronyssinus and Dermatophagoides farinae for patients with allergic rhinoconjunctivitis with or without controlled asthma

Registered drug
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Budesonide
  • Sponsor:LETI Pharma S.L.U.

Study of Saccharomyces boulardii CNCM I-745 to treat symptoms in adults with non-constipated Irritable Bowel Syndrome

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Loperamide Hydrochloride
  • Sponsor:Biocodex

Conjunctivitis allergic+3

Not recruiting

Study on the Effectiveness and Safety of Clustoid MM09 for Patients with Allergic Rhinitis or Rhinoconjunctivitis, with or without Mild to Moderate Asthma

Investigational
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Dermatophagoides Farinae Allergoid, Glutaraldehyde-Modified
  • Sponsor:Inmunotek S.L.

Study on TAR-200 and Cetrelimab for Patients with High-Risk Non-Muscle Invasive Bladder Cancer Who Have Not Received BCG Treatment

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Cetrelimab
  • Sponsor:Janssen Cilag International

Other cities in Spain

The busiest research cities in the country

All 218 cities in Spain

Clinical research in Algeciras

What the registry says about research in the country

01 Oncology Research

Clinical investigations focusing on High-Risk Non-muscle-invasive Bladder Cancer, evaluating innovative combination therapies including TAR-200 and cetrelimab compared to traditional treatments.

  • Bladder Cancer Management
  • Novel Therapeutic Combinations
  • Treatment Effectiveness Assessment

Research aims to improve survival outcomes for patients with early-stage bladder cancer.

02 Allergy & Immunology

Studies examining innovative treatments for allergic rhinitis and rhinoconjunctivitis, with particular focus on dust mite allergy vaccine development.

  • Allergen Immunotherapy
  • Respiratory Allergy Management
  • Vaccine Development

Research focuses on polymerised allergen extracts for moderate to severe allergic conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.